Please wait while the formulary information is being retrieved.
PICATO (INGENOL MEBUTATE)
- Actinic keratosis on the face or scalp
- Actinic keratosis on the trunk or extremities
0.015 % topical gel
- Apply to the affected area(s) on the face and/or scalp by topical route once daily for 3 consecutive days
0.05 % topical gel
- Apply to the affected area(s) of the body, arms, hands and/or legs bytopical route once daily for 2 consecutive days
Actinic keratosis on the face or scalp
- Apply to the affected area(s) on the face and/or scalp by topical route once daily for 3 consecutive days
Actinic keratosis on the trunk or extremities
- Apply to the affected area(s) of the body, arms, hands and/or legs bytopical route once daily for 2 consecutive days
- None
Contraindicated
- None
Severe
Moderate
- None
- None
Contraindicated
- None
Severe
Moderate
- Basal cell carcinoma of skin
- Squamous cell carcinoma of skin
PICATO (INGENOL MEBUTATE)
- Actinic keratosis on the face or scalp
- Actinic keratosis on the trunk or extremities
- None
- Blistering skin
- Erythema
- Headache disorder
- Pain
- Periorbital edema
- Pharyngitis
- Pruritus of skin
- Skin crusting
- Skin irritation
- Skin scaling
- Skin swelling
- Superficial skin ulcer
More Frequent
Severe
Less Severe
- Administration site infection
- Treatment site sequelae
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Acute chemical conjunctivitis
- Anaphylaxis
- Corneal burn
- Herpes zoster
- Keratoacanthoma
- Squamous cell carcinoma of skin
Less Severe
- Basal cell carcinoma of skin
- Conjunctivitis
- Contact dermatitis
- Eyelid edema
- Ocular pain
- Skin pigmentation enhancement
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Ingenol Mebutate
No established safety and efficacy for use in actinic keratosis in pediatrics.
- 1 Day – 18 Years
- No established safety and efficacy for use in actinic keratosis in pediatrics.
Ingenol
- Severity Level:
C
- Additional Notes: Insufficient human data available
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
Ingenol
Insufficient data available
| General | Excretion Potential | Effect on Infant | Notes |
| Evaluate use carefully | Unknown | Not known; no or inclusive data | Insufficient data available |
No Known Risk
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Actinic keratosis on the face or scalp | |
| L57.0 | Actinic keratosis |
| Actinic keratosis on the trunk or extremities | |
| L57.0 | Actinic keratosis |
| 0-9 | A-Z |
|---|---|
| L57.0 | Actinic keratosis |
| L57.0 | Actinic keratosis |
Formulary Reference Tool